Csenge Advisory Group’s Chemed CHE Stock Holding History

Csenge Advisory Group’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3	Closed	–	–	418
2018 Q3	$0	Buy	+3	New	+$956	﹤0.01%	1114

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Csenge Advisory Group's CHE Position: Q4 2018 in Review

Csenge Advisory Group sold out of Chemed (CHE) in Q4 2018, closing a stake of 3 shares.

Csenge Advisory Group first reported a position in CHE in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 359 funds tracked by Wall St. Rank hold CHE as of Q4 2018.

Csenge Advisory Group reported no remaining Chemed position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 3 Chemed shares in Q4 2018.
Csenge Advisory Group first reported a position in Chemed in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Chemed position peaked at $0 in Q3 2018.
359 funds tracked by Wall St. Rank held Chemed as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.